From Academic Innovation to Capability

---

DefenSight began as a decade of research at Adelaide University, at the intersection of infectious-disease pathology and advanced computational imaging. Our founder, Dr Sonja Frölich, and her collaborators built the high-resolution imaging pipelines used to map how pathogens invade host cells — and how those cells respond.

In 2025 we incorporated DefenSight Pty Ltd to turn that research into an Australian-owned capability, with development aligned to the Defence Trailblazer programme. The aim is straightforward: make sure a biological response is never held up by the manual bottleneck between imaging and decision. We bridge the gap between academic discovery and deployable capability — the "Valley of Death" — by bringing laboratory-grade rigour to the speed that defence and biosecurity work demands.

Vision: To give Australia's defence and biosecurity sectors faster, more defensible decisions through automated, auditable biological intelligence.

Mission: To deliver a sovereign analytical layer for biological threat characterisation — so hazard assessment and countermeasure development are driven by fast, interpretable, reproducible data rather than manual review.

• Scientific integrity. Every output is benchmarked against BSL-2/3 validated controls, so AI-driven results meet the evidentiary standard required for defence and forensic reporting.

• Strategic collaboration. We act as the bridge between biotech research and defence, pairing academic discovery with the operational needs of primes and government.

• Transparency by design. We use human-in-the-loop, interpretable AI. Every result comes with the reasoning behind it — no black boxes.

• Sovereign responsibility. 100% Australian-owned IP, with secure, ethical data handling and domestic data residency, supporting Australia's Sovereign Industrial Capability Priorities.

We're extending the platform toward flexible, containerised deployment — able to run where the data's classification requires it, whether that's an air-gapped laboratory, on-premises systems, or a sovereign, onshore, IRAP-assessed cloud. The direction is a durable, Australian-owned capability for biological threat characterisation that integrates into secure Defence environments rather than dictating them.